## VRSK: Verisk Analytics, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%); PEG 2.70 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($216.70)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Verisk Analytics Inc. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251229T163000 | Bullish | Relevance: 100%
- Verisk Analytics Inc. (VRSK) stock rose 2.00% to $224.74 on Monday, outperforming the S&P 500 Index (SPX) and Dow Jones Industrial Average (DJIA) which saw declines of 0.35% and 0.51% respectively. This marks the third consecutive day of gains for the company's stock, despite a grim overall trading session for the market.

**2. Verisk terminates $2.35bn agreement to purchase AccuLynx**
- Source: Insurance Insider US | 20251229T162316 | Somewhat-Bearish | Relevance: 100%
- Verisk has terminated its definitive agreement to purchase the software as a service platform AccuLynx. The data analytics provider had previously announced in July that it intended to acquire AccuLynx in an all-cash deal worth $2.35bn. The article does not provide reasons for the termination.

**3. Verisk Terminates Agreement to Acquire AccuLynx Amid FTC Review Delay**
- Source: Quiver Quantitative | 20251229T140911 | Neutral | Relevance: 100%
- Verisk has terminated its agreement to acquire AccuLynx due to the FTC not completing its review by the deadline. Consequently, Verisk will redeem $1.50 billion in senior notes, and its CEO reaffirmed a commitment to capital allocation and growth opportunities. AccuLynx claims the termination is invalid, which Verisk intends to dispute vigorously.

**4. Verisk Analytics Terminates Multiple Material Agreements**
- Source: TradingView â€” Track All Markets | 20251229T140911 | Somewhat-Bearish | Relevance: 100%
- Verisk Analytics (VRSK) announced the termination of two material agreements. The company ended its merger agreement with ExactLogix (AccuLynx.com) as the transaction was not completed by the outside date of December 26, 2025. Additionally, Verisk's $750 million senior unsecured delayed draw term loan facility automatically terminated on the same date.

**5. Verisk Ends Effort to Acquire AccuLynx**
- Source: GlobeNewswire | 20251229T140833 | Neutral | Relevance: 100%
- Verisk (Nasdaq: VRSK) announced the termination of its agreement to acquire AccuLynx following the FTC's failure to complete its review by the December 26, 2025 deadline. The company will redeem $1.50 billion in senior notes issued for the acquisition but maintains confidence in its capital allocation strategy and long-term growth targets. AccuLynx disputes the termination, which Verisk intends to vigorously defend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $270 | $290 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.31M) |
| Sells | 5 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (+2.0%)
- Blackrock Inc.: 9.4% (+5.5%)
- State Street Corpora: 4.3% (-1.3%)
- Alliancebernstein L.: 3.8% (+3.1%)
- FMR, LLC: 3.1% (-22.9%)

### Key Risks

1. Long-term trend broken: trading 16.5% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.70 signals overvaluation risk, limited margin of safety. Forward P/E 29.4x stretched relative to 10% growth. Quality metrics strong (ROE 268%, ROA 16%, margin 30%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $31.4B |
| Beta | 0.81 |
| 52W Range | $197.00 - $322.92 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.70 |
| Forward P/E | 29.4 |
| Current P/E | 32.4 |
| YoY Growth | 10.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.9% over 5 days). Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 at 2.1% confirms short-term momentum alignment. Below SMA200 (0.83x), long-term trend not supportive. MACD histogram positive (0.80), confirming momentum. RSI neutral at 58. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.57% (CS: 92) | Neutral |
| RSI_14 | 58.3 | Neutral |
| MACD Histogram | 0.80 | Bullish |
| vs SMA20 | 1.023x | Above |
| vs SMA50 | 1.015x | Above |
| vs SMA200 | 0.835x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $224.74
- **Stop Loss:** $216.70 (3.6% risk)
- **Target:** $232.78 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 171
- **Position Value:** $38,430.54
- **Portfolio %:** 38.43%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-02-25 (Est: $1.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.70 | $1.72 | +1.0% |
| 2025Q2 | $1.77 | $1.88 | +6.1% |
| 2025Q1 | $1.68 | $1.73 | +2.8% |
| 2024Q4 | $1.60 | $1.61 | +0.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*